+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Cyfendus Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

  • PDF Icon

    Report

  • 175 Pages
  • April 2025
  • Region: Global
  • The Business Research Company
  • ID: 6074091
This Cyfendus market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

Market growth during the historic period can be attributed to factors such as increased government focus on biosecurity, a greater emphasis on post-exposure prophylaxis for anthrax, federal support for vaccine stockpiling programs, the demand for faster vaccine development in emergencies, and the introduction of anthrax monoclonal antibodies.

In the forecast period, growth is expected to be driven by the emergence of new anthrax threats, growing public health concerns, expanded government contracts and funding, the increasing need for multi-dose vaccines, and the expansion of global vaccination programs. Key trends in this period include ongoing public-private partnerships, promising clinical trial results, innovations in vaccine adjuvants, initiatives for public health emergency preparedness, and a continued focus on the consistency and safety of anthrax vaccines.

The increasing incidence of anthrax is expected to drive the growth of the cyfendus market in the coming years. Anthrax incidence refers to the frequency of anthrax cases within a specific population or geographic area over a defined period. The rising number of anthrax cases can be attributed to factors such as increased human-animal interaction in endemic areas, environmental conditions that disturb soils and release anthrax spores, and limited vaccination coverage in livestock populations. Cyfendus is used for post-exposure protection by stimulating the immune system to produce antibodies against the anthrax bacteria when given alongside antibiotics. For instance, in December 2023, the World Health Organization (WHO) reported 684 suspected human anthrax cases in Zambia, including four fatalities, with a case fatality ratio (CFR) of 0.6%. The highest number of cases was reported in the Sinazongwe district, which accounted for 42% of the total. This increase in anthrax incidence is driving demand for cyfendus.

Rising healthcare investments are expected to boost the growth of the cyfendus market. Healthcare investment refers to the allocation of financial resources toward improving public health outcomes, including funding medical research, healthcare infrastructure, and pharmaceuticals. The growing healthcare investment is driven by factors such as the increasing demand for innovative treatments, advancements in medical technology, and the need for efficient healthcare systems. These investments are crucial for the development, approval, and distribution of vaccines such as Cyfendus, which are essential for enhancing public health security. For example, the UK’s healthcare expenditure reached approximately $348 billion in 2022, marking a 0.7% increase from the previous year. This growing investment supports the availability of vital vaccines such as Cyfendus.

An emerging trend in the cyfendus market is the development of innovative anthrax protection solutions, particularly in high-risk environments. The Cyfendus vaccine provides effective protection against anthrax, either through pre-exposure vaccination or post-exposure prophylaxis. In July 2023, Emergent BioSolutions received FDA approval for Cyfendus (Anthrax Vaccine Adsorbed, Adjuvanted) for post-exposure prophylaxis in individuals aged 18 to 65. The vaccine is used in conjunction with recommended antibiotics and has demonstrated efficacy in animal models of inhalational anthrax. Cyfendus is administered in two doses over 14 days and is particularly critical during large-scale public health emergencies involving anthrax. As such, the development of these innovative solutions is propelling the growth of the cyfendus market.

The key company operating in the cyfendus market is Emergent BioSolutions Inc.

North America was the largest region in the cyfendus market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cyfendus report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the cyfendus market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Cyfendus is a branded intramuscular vaccine containing anthrax vaccine adsorbed and adjuvanted, designed to protect against anthrax infections. It is intended to prevent anthrax caused by Bacillus anthracis, typically following potential exposure. The vaccine prompts the body to produce protective antibodies against the anthrax bacteria. It is usually administered alongside antibiotics as part of a post-exposure prophylaxis regimen to minimize the risk of developing the disease.

The primary routes of administration for cyfendus are parenteral and oral. Parenteral refers to administering medications or nutrients by any route other than the digestive tract, commonly through injection or infusion. It is used for pre-exposure prophylaxis, post-exposure prophylaxis, and for special populations. Cyfendus is distributed through hospital pharmacies, outpatient clinics, and specialty pharmacies.

The cyfendus market research report is one of a series of new reports that provides cyfendus market statistics, including cyfendus industry global market size, regional shares, competitors with a cyfendus market share, detailed cyfendus market segments, market trends and opportunities, and any further data you may need to thrive in the cyfendus industry. This cyfendus market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cyfendus market consists of sales of biodefense vaccines, antibiotics, autoinjectors, and vaccine adjuvants. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.

Table of Contents

1. Executive Summary2. Cyfendus Market Characteristics
3. Cyfendus Market Biologic Drug Characteristics
3.1. Molecule Type
3.2. Route of Administration (ROA)
3.3. Mechanism of Action (MOA)
3.4. Safety and Efficacy
4. Cyfendus Market Trends and Strategies5. Cyfendus Market -Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, and the Recovery from COVID-19 on the Market
6. Global Cyfendus Growth Analysis and Strategic Analysis Framework
6.1. Global Cyfendus PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
6.2. Analysis of End Use Industries
6.3. Global Cyfendus Market Growth Rate Analysis
6.4. Global Cyfendus Historic Market Size and Growth, 2019-2024, Value ($ Million)
6.5. Global Cyfendus Forecast Market Size and Growth, 2024-2029, 2034F, Value ($ Million)
6.6. Global Cyfendus Total Addressable Market (TAM)
7. Global Cyfendus Pricing Analysis & Forecasts
8. Cyfendus Market Segmentation
8.1. Global Cyfendus Market, Segmentation by Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Parenteral
  • Oral
8.2. Global Cyfendus Market, Segmentation by Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Pre-Exposure Prophylaxis
  • Post-Exposure Prophylaxis
  • Special Populations
8.3. Global Cyfendus Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Hospital Pharmacies
  • Outpatient Clinics
  • Specialty Pharmacies
9. Global Cyfendus Epidemiology of Clinical Indications
9.1. Drug Side Effects
9.2. Incidence and Prevalence of Clinical Indications
10. Cyfendus Market Regional and Country Analysis
10.1. Global Cyfendus Market, Split by Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
10.2. Global Cyfendus Market, Split by Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
11. Asia-Pacific Cyfendus Market
11.1. Asia-Pacific Cyfendus Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Cyfendus Market, Segmentation by Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
11.3. Asia-Pacific Cyfendus Market, Segmentation by Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
11.4. Asia-Pacific Cyfendus Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
12. China Cyfendus Market
12.1. China Cyfendus Market Overview
12.2. China Cyfendus Market, Segmentation by Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million
12.3. China Cyfendus Market, Segmentation by Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million
12.4. China Cyfendus Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million
13. India Cyfendus Market
13.1. India Cyfendus Market, Segmentation by Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
13.2. India Cyfendus Market, Segmentation by Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
13.3. India Cyfendus Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
14. Japan Cyfendus Market
14.1. Japan Cyfendus Market Overview
14.2. Japan Cyfendus Market, Segmentation by Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
14.3. Japan Cyfendus Market, Segmentation by Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
14.4. Japan Cyfendus Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
15. Australia Cyfendus Market
15.1. Australia Cyfendus Market, Segmentation by Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
15.2. Australia Cyfendus Market, Segmentation by Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
15.3. Australia Cyfendus Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
16. South Korea Cyfendus Market
16.1. South Korea Cyfendus Market Overview
16.2. South Korea Cyfendus Market, Segmentation by Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
16.3. South Korea Cyfendus Market, Segmentation by Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
16.4. South Korea Cyfendus Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
17. Western Europe Cyfendus Market
17.1. Western Europe Cyfendus Market Overview
17.2. Western Europe Cyfendus Market, Segmentation by Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
17.3. Western Europe Cyfendus Market, Segmentation by Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
17.4. Western Europe Cyfendus Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
18. UK Cyfendus Market
18.1. UK Cyfendus Market, Segmentation by Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
18.2. UK Cyfendus Market, Segmentation by Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
18.3. UK Cyfendus Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
19. Germany Cyfendus Market
19.1. Germany Cyfendus Market, Segmentation by Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
19.2. Germany Cyfendus Market, Segmentation by Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
19.3. Germany Cyfendus Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
20. France Cyfendus Market
20.1. France Cyfendus Market, Segmentation by Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
20.2. France Cyfendus Market, Segmentation by Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
20.3. France Cyfendus Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
21. Eastern Europe Cyfendus Market
21.1. Eastern Europe Cyfendus Market Overview
21.2. Eastern Europe Cyfendus Market, Segmentation by Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
21.3. Eastern Europe Cyfendus Market, Segmentation by Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
21.4. Eastern Europe Cyfendus Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
22. North America Cyfendus Market
22.1. North America Cyfendus Market Overview
22.2. North America Cyfendus Market, Segmentation by Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
22.3. North America Cyfendus Market, Segmentation by Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
22.4. North America Cyfendus Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
23. USA Cyfendus Market
23.1. USA Cyfendus Market Overview
23.2. USA Cyfendus Market, Segmentation by Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
23.3. USA Cyfendus Market, Segmentation by Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
23.4. USA Cyfendus Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
24. Canada Cyfendus Market
24.1. Canada Cyfendus Market Overview
24.2. Canada Cyfendus Market, Segmentation by Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
24.3. Canada Cyfendus Market, Segmentation by Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
24.4. Canada Cyfendus Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
25. South America Cyfendus Market
25.1. South America Cyfendus Market Overview
25.2. South America Cyfendus Market, Segmentation by Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
25.3. South America Cyfendus Market, Segmentation by Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
25.4. South America Cyfendus Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
26. Middle East Cyfendus Market
26.1. Middle East Cyfendus Market Overview
26.2. Middle East Cyfendus Market, Segmentation by Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
26.3. Middle East Cyfendus Market, Segmentation by Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
26.4. Middle East Cyfendus Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
27. Africa Cyfendus Market
27.1. Africa Cyfendus Market Overview
27.2. Africa Cyfendus Market, Segmentation by Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
27.3. Africa Cyfendus Market, Segmentation by Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
27.4. Africa Cyfendus Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
28. Cyfendus Market Competitive Landscape and Company Profiles
28.1. Cyfendus Market Competitive Landscape
28.2. Cyfendus Market Company Profiles
28.2.1. Emergent BioSolutions Inc. Overview, Products and Services, Strategy and Financial Analysis
29. Global Cyfendus Market Pipeline Analysis
29.1. High Level Clinic Trail Information
30. Global Cyfendus Market Competitive Benchmarking and Dashboard31. Key Mergers and Acquisitions in the Cyfendus Market32. Recent Developments in the Cyfendus Market
33. Cyfendus Market High Potential Countries, Segments and Strategies
33.1 Cyfendus Market in 2029 - Countries Offering Most New Opportunities
33.2 Cyfendus Market in 2029 - Segments Offering Most New Opportunities
33.3 Cyfendus Market in 2029 - Growth Strategies
33.3.1 Market Trend Based Strategies
33.3.2 Competitor Strategies
34. Appendix
34.1. Abbreviations
34.2. Currencies
34.3. Historic and Forecast Inflation Rates
34.4. Research Inquiries
34.5. About the Analyst
34.6. Copyright and Disclaimer

Executive Summary

Cyfendus Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cyfendus market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase:

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Description

Where is the largest and fastest growing market for cyfendus? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cyfendus market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) by Route of Administration: Parenteral; Oral
2) by Clinical Indications: Pre-Exposure Prophylaxis; Post-Exposure Prophylaxis; Special Populations
3) by Distribution Channel: Hospital Pharmacies; Outpatient Clinics; Specialty Pharmacies

Key Companies Mentioned: Emergent BioSolutions Inc.

Countries: Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Companies Mentioned

  • Emergent BioSolutions Inc.